Biocells
Latest round
- Series B
Last raised
- Nov 2023
Total raised
- Undisclosed
Investors
- 6
About Biocells
Established in 2009 and based in Beijing, China, Biocells is an innovative drug discovery and development company for neurological diseases, focusing on the prevention and treatment of neurological damage in the full disease cycle of stroke, among others. The company has been recognized as a national high-tech enterprise, and has obtained 36 domestic and international invention patents for its neurocellular protective agent products (including 11 patents in the countries where Europe is in force). By building a platform for small molecule and peptide drug research and development, in vitro molecular and cellular level drug screening, and in vivo animal level drug efficacy evaluation, the company provides services such as prevention and treatment of neurological injuries throughout the disease cycle of stroke, neuroprotection of ischemic and hemorrhagic strokes, cerebral edema, and neuro prosthetics. Specific drugs include BXOS110, a neuro cellular protective agent, and BXOS116 and BXOS401, which are used for nerve repair and nerve regeneration during the recovery period of stroke.69 million.
Who invested in Biocells
6 investors across 2 rounds
See all investors in Biocells
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biocells
Who invested in Biocells?
Biocells has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biocells raised?
Biocells has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Biocells last raise money?
Biocells's most recent round on record is a Series B, in Nov 2023.
What does Biocells do?
Established in 2009 and based in Beijing, China, Biocells is an innovative drug discovery and development company for neurological diseases, focusing on the prevention and treatment of neurological damage in the full disease cycle of stroke, among others.
Where is Biocells headquartered?
Biocells is headquartered in Beijing, China.
Which VCs invest in companies like Biocells?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Biocells's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Biocells? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.